Upcoming Workshops
For Prostate Cancer
Past workshops
For All Cancers
- What’s New in Precision Medicine
- Understanding Diagnostic Technologies and Biomarkers
- Clinical Trials: How They Transform the Treatment of Cancer
- Understanding Diagnostic Technologies and Biomarkers
- Chemotherapy Treatment Side Effects: Prevention & Management
- Clinical Trials: How They Transform the Treatment of Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- How Diagnostic Technologies and Biomarkers Improve Treatment Decisions for People Living with Cancer
- Trends in Oncology and Treatment Planning: What You Need to KnowPart I of Life with Cancer: A Guide to Getting the Best Care
For Acute Lymphoblastic Leukemia
For Acute Myeloid Leukemia
For Bladder Cancer
For Bone Cancer
For Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- What’s New in Precision Medicine
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Lobular Breast Cancer: Treatment Progress
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
For Chronic Lymphocytic Leukemia
For Chronic Myelogenous Leukemia
For Colorectal Cancer
For Cutaneous T-Cell Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Diffuse Large B-Cell Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Endometrial Cancer
For Follicular Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Gastric Cancer
For Gastrointestinal Stromal Tumors
For Head and Neck Cancer
For Hodgkin Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Leukemia
For Liver Cancer
For Lung Cancer
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Small Cell Lung Cancer: Biomarker Testing & Treatment TrendsPart II of Living with Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer: What's NewPart I of Living with Non-Small Cell Lung Cancer
- What’s New in Diagnostic Technologies for People Living with Small Cell Lung CancerPart II of Living with Small Cell Lung Cancer
- Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung CancerPart III of Living with Non-Small Cell Lung Cancer
- Small Cell Lung Cancer: Treatment UpdatePart I of Living with Small Cell Lung Cancer
For Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Mantle Cell Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Marginal Zone Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Melanoma
For Mesothelioma
For Metastatic Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- What’s New in Precision Medicine
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Lobular Breast Cancer: Treatment Progress
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer
For Multiple Myeloma
For Myeloproliferative Neoplasms
For Non-Hodgkin Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Ovarian Cancer
For Peripheral T-Cell Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Prostate Cancer
For Skin Cancer
For Small Lymphocytic Lymphoma
- CAR T-Cell Therapy: What’s New
- Updates from the 2023 American Society of Hematology (ASH) Annual Meeting
- New Perspectives in the Treatment of Peripheral T-Cell Lymphoma (PTCL)
- What’s New in Precision Medicine
- Update on CAR T-Cell Therapies
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Non-Hodgkin Lymphoma: Current Treatment Progress
- Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
For Stomach Cancer
For Thyroid Cancer
For Triple Negative Breast Cancer
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- What’s New in Precision Medicine
- Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
- Lobular Breast Cancer: Treatment Progress
- The Benefits of Clinical Trials for Triple Negative Breast Cancer
- Metastatic Triple Negative Breast CancerPart I of Living with Metastatic Triple Negative Breast Cancer
- Metastatic Breast Cancer: Treatment Updates
- HER2-Positive Metastatic Breast Cancer: What’s New in Treatment & Quality-of-Life
- The Role of Radiation Therapy in the Treatment of Breast Cancer